 |
Market Cap | 34.65B | EPS (ttm) | 10.06 |
P/E | 23.77 | EPS this Y | -15.30% |
Forward P/E | 15.13 | EPS next Y | 5.58% |
PEG | 158.50 | EPS past 5Y | 11.85% |
P/S | 3.61 | EPS next 5Y | 0.15% |
P/B | 2.39 | EPS Q/Q | -106.00% |
Dividend | - | Sales Q/Q | 6.20% |
Insider Own | 0.61% | Inst Own | 87.22% |
Insider Trans | -0.06% | Inst Trans | 0.83% |
Short Float | 1.83% | Earnings | Nov 08/b |
Analyst Recom | 1.55 | Target Price | 317.30 |
Avg Volume | 977.83K | 52W Range | 220.86 - 319.76 |
|
|
Today | Upgrade |
Raymond James |
Mkt Perform → Outperform |
$283 |
|
|
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
BIOGEN INC. | 10% Owner | Sep 26 | Sale | 0.50 | 6,000,000 | 3,000,000 | 17,652,466 | Sep 28 05:30 PM | Singhal Priya | Head of Development | Sep 05 | Sale | 269.43 | 431 | 116,124 | 3,354 | Sep 06 06:06 PM | Singhal Priya | Head of Development | Sep 01 | Option Exercise | 0.00 | 1,668 | 0 | 4,592 | Sep 06 06:06 PM | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sep 01 | Option Exercise | 0.00 | 5,285 | 0 | 14,060 | Sep 06 06:08 PM | Singhal Priya | Head of Development | Jul 03 | Sale | 282.87 | 81 | 22,912 | 2,924 | Jul 05 05:33 PM |
|
|
 |
 |
Market Cap | 321.78M | EPS (ttm) | -2.93 |
P/E | - | EPS this Y | -276.47% |
Forward P/E | 13.81 | EPS next Y | 223.33% |
PEG | - | EPS past 5Y | -82.53% |
P/S | 0.64 | EPS next 5Y | - |
P/B | 1.81 | EPS Q/Q | 93.38% |
Dividend | - | Sales Q/Q | -6.12% |
Insider Own | 48.04% | Inst Own | 31.76% |
Insider Trans | 3.92% | Inst Trans | 2.15% |
Short Float | 3.42% | Earnings | Nov 07/b |
Analyst Recom | 2.33 | Target Price | 6.50 |
Avg Volume | 163.72K | 52W Range | 0.80 - 5.09 |
|
|
Today | Upgrade |
Canaccord Genuity |
Hold → Buy |
$7 |
|
|
Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Bihl Anthony P III | Interim CEO | Aug 18 | Buy | 4.14 | 26,595 | 110,071 | 26,595 | Aug 22 06:20 PM | Bihl Anthony P III | Interim CEO | Aug 18 | Buy | 4.14 | 13,290 | 55,005 | 138,290 | Aug 22 06:20 PM | Juniper Investment Company, LL | 10% Owner | Aug 14 | Buy | 4.79 | 14,985 | 71,778 | 6,833,857 | Aug 15 04:05 PM | Bartholdson John A. | Director | Aug 14 | Buy | 4.79 | 14,985 | 71,753 | 6,833,857 | Aug 15 05:48 PM | Bartholdson John A. | Director | Aug 11 | Buy | 4.60 | 50,037 | 229,935 | 6,818,872 | Aug 15 05:48 PM |
|
|
 |
 |
Market Cap | 37.78B | EPS (ttm) | -0.11 |
P/E | - | EPS this Y | 52.99% |
Forward P/E | 63.69 | EPS next Y | 20.43% |
PEG | - | EPS past 5Y | -77.99% |
P/S | 18.82 | EPS next 5Y | 33.30% |
P/B | 20.90 | EPS Q/Q | 178.35% |
Dividend | - | Sales Q/Q | 25.43% |
Insider Own | 18.06% | Inst Own | 68.86% |
Insider Trans | -3.79% | Inst Trans | 0.83% |
Short Float | 3.39% | Earnings | Nov 07/b |
Analyst Recom | 1.78 | Target Price | 118.58 |
Avg Volume | 4.28M | 52W Range | 61.34 - 120.26 |
|
|
Today | Upgrade |
Stifel |
Hold → Buy |
$98 → $140 |
|
|
Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Le-Quoc on June 4, 2010, and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Blitzer Adam | Chief Operating Officer | Dec 05 | Sale | 117.19 | 6,800 | 796,888 | 174,237 | Dec 06 05:07 PM | Pomel Olivier | Chief Executive Officer | Dec 04 | Sale | 117.26 | 104,346 | 12,235,387 | 299,075 | Dec 06 05:03 PM | OBSTLER DAVID M | Chief Financial Officer | Dec 04 | Sale | 116.78 | 14,608 | 1,705,887 | 246,009 | Dec 06 05:05 PM | Le-Quoc Alexis | Chief Technology Officer | Dec 04 | Sale | 116.78 | 13,783 | 1,609,545 | 247,328 | Dec 06 05:03 PM | Agarwal Amit | President | Dec 04 | Sale | 116.78 | 11,037 | 1,288,875 | 247,071 | Dec 06 05:04 PM |
|
|
|  |
 |
Market Cap | 89.98B | EPS (ttm) | 5.54 |
P/E | 5.48 | EPS this Y | -45.28% |
Forward P/E | 7.42 | EPS next Y | 4.68% |
PEG | 0.94 | EPS past 5Y | 45.27% |
P/S | 0.80 | EPS next 5Y | 5.80% |
P/B | 1.84 | EPS Q/Q | -71.79% |
Dividend | 11.67% | Sales Q/Q | -39.33% |
Insider Own | 0.00% | Inst Own | 2.03% |
Insider Trans | - | Inst Trans | 2.38% |
Short Float | 0.25% | Earnings | Oct 27/b |
Analyst Recom | 1.60 | Target Price | 38.38 |
Avg Volume | 2.58M | 52W Range | 24.31 - 35.05 |
|
|
Today | Upgrade |
BofA Securities |
Neutral → Buy |
|
|
|
Equinor ASA engages in the exploration, production, transport, refining, and marketing of petroleum and petroleum-derived products. It operates through the following segments: Exploration and Production Norway, Exploration and Production International, Exploration and Production USA, Marketing, Midstream, and Processing, Renewables, and and Other. The Exploration and Production Norway segment includes the commercial development of oil and gas portfolios on the Norwegian continental shelf. The Exploration and Production International segment covers offshore and onshore activities in the USA, Mexico, and other operations worldwide. The Exploration and Production USA segment covers both onshore and offshore exploration, development, and Production of oil and gas in USA. The Marketing, Midstream, and Processing segment markets and trades of crude oil and condensate, natural gas, NGL and refined products. The Renewables segment focuses on offshore wind,and integrated solutions for onshore renewables. The Other segment includes projects, drilling and procurement, the business area technology, digital and innovation, and corporate staffs and support functions. The company was founded on September 18, 1972 and is headquartered in Stavanger, Norway. |
|
 |
 |
Market Cap | 19.48B | EPS (ttm) | 7.42 |
P/E | 25.46 | EPS this Y | -21.03% |
Forward P/E | 22.88 | EPS next Y | 13.50% |
PEG | 5.66 | EPS past 5Y | 8.30% |
P/S | 1.48 | EPS next 5Y | 4.50% |
P/B | 4.85 | EPS Q/Q | -30.07% |
Dividend | 0.79% | Sales Q/Q | -17.57% |
Insider Own | 20.91% | Inst Own | 77.02% |
Insider Trans | -0.09% | Inst Trans | -3.51% |
Short Float | 2.74% | Earnings | Oct 17/a |
Analyst Recom | 2.04 | Target Price | 198.55 |
Avg Volume | 769.91K | 52W Range | 163.66 - 209.21 |
|
|
Today | Upgrade |
UBS |
Sell → Neutral |
$205 |
|
|
J.B. Hunt Transport Services, Inc. engages in the provision of logistics solutions. It operates through the following segments: Intermodal (JBI), Dedicated Contract Services (DCS), Integrated Capacity Solutions (ICS), Final Mile Services (FMS) and Truckload (JBT). The JBI segment offers intermodal freight operations for rail carriers. The DCS segment includes private fleet conversion and final-mile delivery services. The ICS segment provides single-source logistics management for clients who intend to outsource their transportation activities. It offers flatbed, refrigerated, expedited, less-than-truckload, dry-van, and intermodal freight services. The FMS segment provides final-mile delivery services to customers through a nationwide network of cross-dock and other delivery system network locations. The JBT segment is responsible for full-load, dry-van freight that is transported via roads and highways. The company was founded by Johnnie Bryan Hunt, Sr. and Johnelle D. Hunt on August 10, 1961, and is headquartered in Lowell, AR. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Simpson Shelley | President | Dec 05 | Sale | 188.50 | 5,350 | 1,008,475 | 82,964 | Dec 06 01:05 PM | Frazier Spencer | EVP of Sales and Marketing | Nov 30 | Sale | 184.77 | 1,527 | 282,145 | 4,522 | Dec 01 02:17 PM | Frazier Spencer | EVP of Sales and Marketing | Oct 31 | Option Exercise | 0.00 | 4,775 | 0 | 7,835 | Nov 02 12:15 PM | Webb Brian | EVP- Final Mile Services | Oct 31 | Option Exercise | 0.00 | 2,754 | 0 | 17,057 | Nov 02 12:15 PM | BOATTINI JENNIFER | SR VP Legal/General Counsel | Oct 31 | Option Exercise | 0.00 | 3,339 | 0 | 15,098 | Nov 02 12:16 PM |
|
|
|  |
 |
Market Cap | 2.21B | EPS (ttm) | -1.37 |
P/E | - | EPS this Y | 232.45% |
Forward P/E | 31.23 | EPS next Y | 39.52% |
PEG | - | EPS past 5Y | -24.73% |
P/S | 3.63 | EPS next 5Y | 34.40% |
P/B | 5.01 | EPS Q/Q | 18.25% |
Dividend | - | Sales Q/Q | 7.06% |
Insider Own | 4.04% | Inst Own | 100.57% |
Insider Trans | -4.66% | Inst Trans | -1.98% |
Short Float | 5.87% | Earnings | Nov 01/a |
Analyst Recom | 1.88 | Target Price | 38.71 |
Avg Volume | 545.78K | 52W Range | 18.91 - 38.15 |
|
|
Today | Upgrade |
Stephens |
Equal-Weight → Overweight |
$36 → $46 |
|
|
Q2 Holdings, Inc. engages in the provision of digital banking and lending solutions. It offers its solutions to financial institutions, financial technology companies, alternative finance companies, and other innovative companies, wishing to incorporate banking into their customer engagement and servicing strategies. The company was founded by Robert Hank Seale III in 2004 and is headquartered in Austin, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Mehok David J | Chief Financial Officer | Nov 30 | Sale | 36.53 | 400 | 14,612 | 165,632 | Dec 01 04:37 PM | Mehok David J | Chief Financial Officer | Nov 29 | Sale | 36.39 | 400 | 14,556 | 166,032 | Dec 01 04:37 PM | Offerdahl James | Director | Nov 22 | Sale | 35.20 | 493 | 17,354 | 19,296 | Nov 27 04:09 PM | Seale R. H. | Director | Oct 13 | Sale | 32.13 | 22,300 | 716,499 | 404,054 | Oct 17 04:29 PM | Seale R. H. | Director | Sep 15 | Sale | 32.59 | 22,300 | 726,757 | 426,354 | Sep 18 04:38 PM |
|
|
 |
 |
Market Cap | 9.58B | EPS (ttm) | 1.44 |
P/E | 29.13 | EPS this Y | -13.99% |
Forward P/E | 19.72 | EPS next Y | 4.12% |
PEG | 17.55 | EPS past 5Y | 60.36% |
P/S | 4.90 | EPS next 5Y | 1.66% |
P/B | 2.60 | EPS Q/Q | -5.78% |
Dividend | - | Sales Q/Q | -4.75% |
Insider Own | 0.42% | Inst Own | 70.14% |
Insider Trans | 0.00% | Inst Trans | 0.59% |
Short Float | 1.50% | Earnings | Oct 30/a |
Analyst Recom | 1.95 | Target Price | 48.80 |
Avg Volume | 1.23M | 52W Range | 34.74 - 51.18 |
|
|
Today | Upgrade |
Goldman |
Neutral → Buy |
$50 |
|
|
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands. |
|
|  |
 |
Market Cap | 4.20B | EPS (ttm) | 1.80 |
P/E | 13.25 | EPS this Y | -46.49% |
Forward P/E | 16.03 | EPS next Y | 5.11% |
PEG | 73.60 | EPS past 5Y | 2.35% |
P/S | 0.74 | EPS next 5Y | 0.18% |
P/B | 1.42 | EPS Q/Q | -71.55% |
Dividend | 1.33% | Sales Q/Q | -19.30% |
Insider Own | 68.43% | Inst Own | 28.21% |
Insider Trans | 0.00% | Inst Trans | 0.03% |
Short Float | 2.73% | Earnings | Nov 02/b |
Analyst Recom | 2.00 | Target Price | 26.57 |
Avg Volume | 582.71K | 52W Range | 21.39 - 31.74 |
|
|
Today | Upgrade |
Wells Fargo |
Underweight → Equal Weight |
$23 → $25 |
|
|
Schneider National, Inc. provides transportation and logistics services. The firm's transportation solutions include van truckload, dedicated, regional, bulk, intermodal, brokerage, supply chain management, port logistics services and engineering, and freight payment services. It operates through the following business segments: Truckload, Intermodal and Logistics. The Truckload segment consists of freight transported and delivered with standard and specialty equipment by employed drivers in company trucks and by owner-operators. The Intermodal segment consists of door-to-door container on flat car service by a combination of rail and over-the-road transportation, in association with rail carrier partners. The Logistics segment consists of non-asset freight brokerage services, supply chain services and import/export services. The company was founded by A. J. Schneider in 1935 and is headquartered in Green Bay, WI. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Reich Robert M JR | EVP, Chief Admin Officer | Feb 06 | Option Exercise | 18.99 | 6,000 | 113,940 | 99,645 | Feb 07 09:33 PM | Reich Robert M JR | EVP, Chief Admin Officer | Feb 06 | Sale | 29.64 | 6,000 | 177,840 | 93,645 | Feb 07 09:33 PM | Devgun Shaleen | Chief Innov. & Tech. Officer | Feb 01 | Sale | 27.00 | 10,000 | 270,000 | 124,497 | Feb 02 05:11 PM |
|
|
 |
 |
Market Cap | 1.12B | EPS (ttm) | 17.43 |
P/E | 1.84 | EPS this Y | -106.07% |
Forward P/E | - | EPS next Y | -241.88% |
PEG | - | EPS past 5Y | 118.73% |
P/S | 0.90 | EPS next 5Y | - |
P/B | 0.43 | EPS Q/Q | 244.94% |
Dividend | - | Sales Q/Q | -70.59% |
Insider Own | 23.58% | Inst Own | 79.73% |
Insider Trans | 0.00% | Inst Trans | 0.28% |
Short Float | 14.44% | Earnings | Nov 08/b |
Analyst Recom | 2.20 | Target Price | 34.20 |
Avg Volume | 994.70K | 52W Range | 18.01 - 43.93 |
|
|
Today | Upgrade |
Seaport Research Partners |
Neutral → Buy |
$38 |
|
|
Sphere Entertainment Co. engages in the provision of live entertainment and media services. It operates through the following segments: Entertainment, MSG Networks, and Other. The Entertainment segment is involved in the bookings business, which features a variety of live entertainment and sports experiences. The MSG Networks segment delivers a range of live sports content, entertainment networks, and other programming. The company was founded in 2010 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Ranji Gautam | EVP, CFO & Treasurer | Nov 03 | Option Exercise | 0.00 | 656 | 0 | 1,523 | Nov 06 04:05 PM | Sphere Entertainment Co. | 10% Owner | Sep 22 | Sale | 31.20 | 8,221,188 | 256,501,066 | 0 | Sep 22 04:05 PM | DOLAN JAMES LAWRENCE | Executive Chairman and CEO | Sep 15 | Option Exercise | 0.00 | 158,703 | 0 | 426,292 | Sep 19 04:15 PM | GREENBERG ANDREA | President/CEO-MSG Networks | Sep 15 | Option Exercise | 0.00 | 48,523 | 0 | 112,410 | Sep 19 04:15 PM | Dolan Ryan Thomas | Director | Sep 15 | Option Exercise | 0.00 | 892 | 0 | 1,812 | Sep 19 04:15 PM |
|
|
 |
 |
Market Cap | 131.59M | EPS (ttm) | -4.71 |
P/E | - | EPS this Y | 78.32% |
Forward P/E | - | EPS next Y | -17.62% |
PEG | - | EPS past 5Y | 24.01% |
P/S | 162.45 | EPS next 5Y | - |
P/B | 1.64 | EPS Q/Q | 74.13% |
Dividend | - | Sales Q/Q | 131.11% |
Insider Own | 8.47% | Inst Own | 40.42% |
Insider Trans | 51.28% | Inst Trans | -91.48% |
Short Float | 6.41% | Earnings | Nov 09/a |
Analyst Recom | 1.00 | Target Price | 13.00 |
Avg Volume | 556.14K | 52W Range | 1.62 - 24.71 |
|
|
Today | Upgrade |
Jefferies |
Hold → Buy |
$15 |
|
|
VistaGen Therapeutics, Inc. is a late clinical-stage biopharmaceutical company, which engages in developing and commercializing medication and treatment for anxiety, depression, and other central nervous system disorders. Its product portfolio includes Fasedienol (PH94B) nasal spray for social anxiety disorder, Itruvone (PH10) nasal spray for depression disorders, AV-101 oral NMDR glycine site antagonist for depression and neurological disorders, PH15 acute treatment for improvement of cognition, PH80 acute management of vasomotor symptoms due to menopause, and PH284 acute management of Wasting syndrome (Cachexia). The company was founded by H. Ralph Snodgrass and Gordon Keller on May 26, 1998 and is headquartered in South San Francisco, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
COMMODORE CAPITAL LP | 10% Owner | Aug 07 | Buy | 23.15 | 775,756 | 17,961,079 | 1,575,000 | Aug 09 04:10 PM |
|
|
|